Bioadaptives Inc (ID) (BDPT)

BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity

LAS VEGAS, June 25, 2026 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT), the parent company of...

BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery

LAS VEGAS, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a science-driven...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night

LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing

LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

Form 10-Q - Quarterly report [Sections 13 or 15(d)]